The PK Saline TUR System from Gyrus Medical combines the safety and efficacyof bipolar radiofrequency energy and saline for "seal-as-you-go"tissue resection and vaporization for treating enlarged prostates and bladdertumors. Benefits include less bleeding, shorter catheterization, and improvedpost-op results, according to the company.
AUA, SUFU publish 2024 guideline for idiopathic overactive bladder
April 25th 2024“This brand new guideline offers options for all patients with OAB with a focus on shared decision-making between patients with OAB and clinicians, as well as a personalized, tailored approach to care,” said Cameron and Smith.
Enzalutamide granted approval in EU for nmHSPC
April 24th 2024The approval is supported by data from the phase 3 EMBARK trial, which demonstrated that enzalutamide with or without leuprolide prolonged metastasis-free survival compared with leuprolide alone in patients with high-risk biochemically recurrent nmHSPC.